StonvexLoading…
StonvexStonvexStonvexCore line items from NVRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.24B | $2.34B | $2.37B | $2.13B |
Operating Income | $4.25M | $30.71M | $87.51M | $-100.90M |
Net Income | $-167.60M | $-129.65M | $-82.96M | $-180.07M |
EPS (Diluted) | $-2.08 | $-1.62 | $-1.04 | $-2.27 |
Total Assets | $2.71B | $2.63B | $2.83B | $2.79B |
Total Liabilities | $2.41B | $2.20B | $2.28B | $2.17B |
Cash & Equivalents | $103.67M | $88.36M | $88.36M | $121.24M |
Free Cash Flow OCF − CapEx | $-39.87M | $-58.53M | $-24.58M | $13.37M |
Shares Outstanding | 81.45M | 80.20M | 79.83M | 79.49M |